Brian Adams
CIK 1636994 · Chief Legal Officer · last filed 2026-03-04
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$10.65M
Companies
3
Total Filings
74
Lifetime Open-Market Net
-$2.08M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| KYMR | Chief Legal Officer | 56,625 | $86.20 | $4.88M | $0 | 2 | 2026-03-04 |
| RLAY | Chief Legal Officer | 389,748 | $14.81 | $5.77M | -$1.82M | 45 | 2025-07-30 |
| KERYX BIOPHARMACEUTICALS INC (KERX) Delisted | General Counsel and Secretary | 126,069 | — | — | -$262.5K | 27 | 2018-02-16 |
Recent Filings · Page 7 of 8
74 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2017-01-06 | KERYX BIOPHARMACEUTICALS INC (KERX) Delisted | Sell (S) | −759 | -$4.7K | EDGAR |
| 2016-10-18 | KERYX BIOPHARMACEUTICALS INC (KERX) Delisted | Sell (S) | −1,106 | -$5.4K | EDGAR |
| 2016-10-06 | KERYX BIOPHARMACEUTICALS INC (KERX) Delisted | Sell (S) | −647 | -$3.5K | EDGAR |
| 2016-07-18 | KERYX BIOPHARMACEUTICALS INC (KERX) Delisted | Sell (S) | −1,083 | -$7.6K | EDGAR |
| 2016-07-06 | KERYX BIOPHARMACEUTICALS INC (KERX) Delisted | Sell (S) | −660 | -$4.4K | EDGAR |
| 2016-04-18 | KERYX BIOPHARMACEUTICALS INC (KERX) Delisted | Sell (S) | −1,060 | -$5.4K | EDGAR |
| 2016-04-07 | KERYX BIOPHARMACEUTICALS INC (KERX) Delisted | Sell (S) | −759 | -$3.4K | EDGAR |
| 2016-02-01 | KERYX BIOPHARMACEUTICALS INC (KERX) Delisted | Grant (A) | +53,750 | $0 | EDGAR |
| 2016-01-20 | KERYX BIOPHARMACEUTICALS INC (KERX) Delisted | Sell (S) | −1,322 | -$4.4K | EDGAR |
| 2016-01-08 | KERYX BIOPHARMACEUTICALS INC (KERX) Delisted | Sell (S) | −3,004 | -$14.5K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.